Inhibitors of cytosolic phospholipase A2

Details for Australian Patent Application No. 2002351182 (hide)

Owner Wyeth

Inventors Chen, Lihren; McKew, John Caedmon; Tam, Steve Yik-Kai; Lee, Katherine Lin; Sum, Fuk-Wah; Hu, Baihua; Clark, James Donald; Behnke, Mark Leo; Thakker, Paresh

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002351182

PCT Number PCT/US02/38311

PCT Pub. Number WO2003/048122

Priority 60/334,588 03.12.01 US; 60/334,605 03.12.01 US; 60/419,664 18.10.02 US; 60/334,591 03.12.01 US

Filing date 2 December 2002

Wipo publication date 17 June 2003

Acceptance publication date 15 January 2009

International Classifications

C07D 491/113 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/4045 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/417 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 209/14 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/334,588 03.12.01 US; 60/334,605 03.12.01 US; 60/419,664 18.10.02 US; 60/334,591 03.12.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002351182

15 January 2009 Application Accepted

  Published as AU-B-2002351182

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351183-Mitotic kinesin inhibitors

2002351181-Methods and compositions for treating lesions of the respiratory epithelium